Lack of Effect of Sleep Apnea on Oxidative Stress in Obstructive Sleep Apnea Syndrome (OSAS) Patients by Simiakakis, M. et al.
Lack of Effect of Sleep Apnea on Oxidative Stress in
Obstructive Sleep Apnea Syndrome (OSAS) Patients
M. Simiakakis
1, F. Kapsimalis
1*, E. Chaligiannis
2, S. Loukides
3, N. Sitaras
2, M. Alchanatis
1
11
st Department of Respiratory Medicine, Medical School, University of Athens, Sotiria Hospital for Chest Diseases, Athens, Greece, 2Department of Pharmacology,
Medical School, University of Athens, Athens, Greece, 32
nd Department of Respiratory Medicine, Medical School, University of Athens, Athens, Greece
Abstract
Purpose: The aim of this study was to evaluate markers of systemic oxidative stress and antioxidant capacity in subjects
with and without OSAS in order to investigate the most important factors that determine the oxidant–antioxidant status.
Methods: A total of 66 subjects referred to our Sleep laboratory were examined by full polysomnography. Oxidative stress
and antioxidant activity were assessed by measurement of the derivatives of reactive oxygen metabolites (d-ROMs) and the
biological antioxidant capacity (BAP) in blood samples taken in the morning after the sleep study. Known risk factors for
oxidative stress, such as age, sex, obesity, smoking, hypelipidemia, and hypertension, were investigated as possible
confounding factors.
Results: 42 patients with OSAS (Apnea-Hypopnea index .15 events/hour) were compared with 24 controls (AHI,5). The
levels of d-ROMS were significantly higher (p=0.005) in the control group but the levels of antioxidant capacity were
significantly lower (p=0.004) in OSAS patients. The most important factors predicting the variance of oxidative stress were
obesity, smoking habit, and sex. Parameters of sleep apnea severity were not associated with oxidative stress. Minimal
oxygen desaturation and smoking habit were the most important predicting factors of BAP levels.
Conclusion: Obesity, smoking, and sex are the most important determinants of oxidative stress in OSAS subjects. Sleep
apnea might enhance oxidative stress by the reduction of antioxidant capacity of blood due to nocturnal hypoxia.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is an increasing
major health concern affecting at least up to 5% of middle aged
subjects in the general population. The main pathophysiologic
feature in OSAS is the repetitive nature of partial or complete
collapse of the upper airway leading to oxyhemoglobin desatura-
tion of various severity. The recognition of the relation of OSAS to
increased cardiovascular morbidity and mortality has increased
the burden of research in the field of this relationship [1].
Oxidative stress has been considered as a major pathogenic
mechanism of atherosclerosis and cardiovascular disease [2]. It
represents an imbalance between the production of free radicals
such as reactive oxygen species (ROS) and the antioxidant system
activity that counteracts their harmful actions. ROS such as
superoxide anion (O2-), hydroxyl radical (OH-) and peroxynitrite
are highly reactive molecules that interact with nucleic acids,
lipids, and proteins leading to injury of the cells. The presence of
systemic oxidative stress in patients with sleep apnea has been
investigated in the last decade as an important mechanism that
link OSAS with endothelial damage and increased risk for
cardiovascular consequences [2]. The cyclical hypoxia - reox-
ygenation sequence that characterise the obstructive events
represents the major pathway related to enhanced production
of free radicals similarly to the ischemia-reperfusion injury in
coronary artery disease through several molecular mechanisms.
Intermittent hypoxia leads to mitochondrial dysfunction, activa-
tion of enzymes that utilize oxygen such as xanthine oxidase or
NADPH, leukocyte activation and endothelial cell dysfunction
thus producing generation of oxidizing agents and an upregula-
tion of inflammatory pathways [3–5]. Tissue hypoxia also has
been implicated in transient depletion of cellular reductants
resulting in disruption of the oxidation-reduction state and thus
contributing to the generation of oxidative stress [6].
Several studies have indicated the presence of higher levels of
oxidative stress [7–12] or decreased activity of the antioxidant
system [13–16] in OSAS patients in comparison to non-OSAS
controls. However there are also studies with contrary results
that failed to demonstrate increased oxidative stress in OSAS
[17–20]. This inconsistency could be explained by the influence
of confounding factors such as diabetes, hypertension and
mainly obesity which is a major source of oxidative stress
independent of OSAS [5]. Obesity is the most common
comorbidity of OSAS presenting in more than 50% of OSAS
patients [1]. Obesity itself has been also considered as a chronic
inflammatory situation related to cardiovascular morbidity and
oxidative stress [4,5]. Thus, it might represent the most
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with cardiovascular morbidity. In a large community cohort
study, it was demonstrated that BMI along with smoking and
diabetes were the most significant and independent factors
associated with systemic oxidative stress markers although the
contribution of coexisting sleep apnea could not be excluded
[21]. The sources of oxidative stress in obesity [22] are similar
to those in OSAS thus the independent role of sleep apnea in
producing oxidative stress has not been fully clarified. In this
study, we evaluated markers of systemic oxidative stress and
antioxidant capacity in subjects with and without OSAS in
order to investigate the most important factors that determine
the oxidant-antioxidant status.
Materials and Methods
Ethics Statement
A written informed consent was obtained from all subjects and
the study was approved by the Sotiria Hospital for Chest Diseases
ethics committee.
Subjects
We examined sixty-six consecutive subjects recruited from
September 2007 to July 2008 from those referred for evaluation
for the presence of sleep apnea to the Sleep Laboratory of
a university hospital. All subjects were given a detailed medical
and sleep interview and had complete physical examination and
blood tests. Exclusion criteria included the presence of diabetes or
any other endocrinologic diseases, renal diseases, cancer history
and chronic airway disease. Patients with rhinitis, sinusitis,
respiratory infections or systemic infections were also excluded.
All subjects had received no therapy with inhaled, oral or nasal
steroids or other anti-inflammatory drugs for 3 months prior to
entry in the study. After completing overnight polysomnography
we classified subjects either as controls with an Apnoea-
Hypopnoea Index (AHI) #5 events/h or as OSAS patients with
an AHI $15 events/h.
Polysomnography
All subjects underwent full night comprehensive polysomno-
graphy. Monitoring included airflow via a nasal pressure
transducer associated with thermistor signals, arterial oxygen
saturation by pulse oximetry, respiratory efforts by abdominal
and thoracic bands and electrocardiography. Sleep staging was
performed via signals of electroencephalogram (EEG), electro-
occulogram (EOG) and submental and pretibial electromyogra-
phy (EMG). An apnea was defined by a .90% decrease in the
thermistor signal of airflow for $10 sec. An hypopnoea was
defined by a .50% reduction of nasal pressure signal lasting for
$10 sec associated with a decrease of $3% in oxygen
saturation or an EEG arousal according to the American
Academy of Sleep Medicine new scoring rules [23]. An event
was defined as obstructive in the presence of respiratory efforts
and central in the absence. The apnea hypopnea index (AHI)
was defined as the number of obstructive and central apneas
and hypopneas per hour of sleep and calculated by dividing the
total number of events by the total sleep time.
Measurements
A venous blood sample of ten milliliters was taken in all subjects
at waking time (8:00am) after overnight fasting. Five milliliters
were used for determining the lipid profile (total cholesterol, LDL
and HDL cholesterol and triglycerides), glucose and creatinine by
routine laboratory techniques. The rest 5 milliliters were
centrifuged at 6000/ min for 5 min and the serum was stored
immediately at 270
C for measurement of oxidative stress and
antioxidant capacity.
Reactive Oxygen Metabolites (d-ROMs Test)
ROMs were measured in serum samples by the Diacron
reactive oxygen metabolites (d-ROM) test (Diacron SPF, Grosseto,
Italy). This test is based on the reaction of hydroperoxides of
a biological sample with transition metals (iron) that catalyze the
formation of free radicals which then oxidize an alchilamine
forming a colored radical detected by photometry at 505 nm.
Ten mL of blood are mixed with 1 ml of an acidic (PH 4.8) buffer
reagent (R2 ) in order to release iron from plasma proteins that will
react with peroxides of the blood to form free radicals, and then
10 mL of a chromogen reagent (R1 reagent, alchilamine ) are
added forming a pink-colored derivative. This colored derivative is
photometrically quantified and the optical density is directly
proportional to the concentration of ROMs. Reference values of
d-ROMs test are between 250 and 300 Carratelli Units (Carr. U.)
i.e. 20–24 mg H2O2/dl, independently of gender and age. Values
higher than 320 indicate increasing levels of oxidative stress in
a linear way up to 500 carr.
Biological Antioxidant Potential (BAP Test)
The total antioxidant capacity was measured by the biological
antioxidant potential (BAP) test (Diacron SPF, Grosseto, Italy).
This method evaluates the reducing power of a biological sample.
A salt of trivalent iron FeCl3 is solved in a given colorless solution
with chelation acid derivative turning its color to red due to the
action of ferric ions. This solution is then decolorized by the
addition of blood serum due to the reduction of ferric ions to
bivalent ions (Fe
2+) caused by the action of antioxidants. The
antioxidant potential of blood plasma can be then evaluated by
assessing photometrically the degree of decolorization which
reflects the amount of reduced ferric ions i.e. the reducing
capacity of blood.
In the BAP method, 10 mL of the blood sample is dissolved in
a colored solution that has been previously obtained by mixing
a source of ferric ions (FeCl3, ferric chloride, R2 reagent) with
a special chromogenic substrate (a thiocyanate-derived compound,
R1 reagent). After a short incubation (5 min), such solution will
decolorize and the intensity of this change will be directly
proportional to the ability of plasma to reduce ferric ions. The
results are expressed in units of mmol/L. Normal reference values
of BAP test are .2200 mmol/L. Values below 2000 mmol/L
indicate an antioxidant deficiency status.
Statistical Methods
Data are expressed as the mean 6 SD. Spearman rank
correlations test was used to explore the correlations between
levels of oxidative stress (d- ROMS values) and antioxidant
capacity (BAP values) with age, BMI, sleep disordered breathing
(SDB) variables and lipid profile parameters. Comparisons
between groups were performed using the student t-test for
continuous variables and chi-square test for categorical variables.
Stepwise multiple regression analyses were performed to in-
vestigate the most significant factors in predicting levels of d-
ROMS and BAP. Statistical significance was defined as a p-value
,0.05. All statistical analyses were made by using the software
programme Statistica version.6.
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Comparison between OSAS and Non-OSAS Groups
42 patients with OSAS (mean AHI: 36.9624.1 events/hour)
were compared with 24 non-OSAS subjects (mean AHI: 3.262.5).
In the OSAS group, patients were older than controls (49.7612.7
vs. 42.8613.1 years, p=0.04) but they had similar BMI (34.468.5
vs. 33.369.5 Kg/m
2, p=0.62). There were no significant
differences between the two groups regarding presence of arterial
hypertension but the control group included a significantly higher
proportion of female subjects and smokers (see table 1). There was
no significant difference in the lipid profile between the two
groups.
The mean level of d-ROMs was significantly higher in the
control group (404.3698.3 vs. 476.4698.8, p=0.005) but the
mean value of antioxidant capacity as evaluated by BAP was
significantly lower in the OSAS group (2092.96467.6 vs.
2410.46304.9, p=0.004). Only 8% of the controls compared
with 21% of patients had values of d-ROMS in the normal range
(below 320). In contrast, as regarding the BAP values, 52% of
patients had values ,2200 compared with only 4% (1 subject) in
the control group.
Correlations
In the whole sample of participants we found that the serum
levels of oxidative stress as expressed by D-ROMs levels had
a significantly positive correlation (see table 2) only with the BMI
(r=0.332, p=0.006) and high density lipoproteins (r=0.266,
p=0.03). There was also a significant negative correlation with the
AHI (r=20.259, p=0.03) and no correlation with the nadir SaO2
(r=0.209, p=0.09) and total sleep time with SaO2,90%
(r=20.222, p=0.18). Instead, the levels of antioxidant capacity
as evaluated by the BAP test (see table 3) were positively correlated
with the nadir SaO2 (r=0.294, p=0.01) and negatively correlated
with triglycerides levels (r=20.287, p=0.01), cholesterol
(r=20.268, p=0.03) and low density lipoproteins (r=20.287,
p=0.01). There was no significant correlation between the BAP
values and the AHI (r=20.191, p=0.12), the total sleep time with
SaO2,90% (r=20.167, p=0.17) or the BMI (r=20.050,
p=0.68).
Multiple Regression Analyses
Separate multiple regression analyses were done with levels of d-
ROMs and BAP values as the dependent variables in order to
examine the most significant factors that could explain their
variance. Independent variables included BMI, age, smoking
habit, presence of hypertension, AHI, nadir SaO2, TST,90%,
total cholesterol, HDL, LDL and triglycerides. As regarding the
level of oxidative stress as expressed by the d-ROMs levels, in
a model explaining about 32% (adjusted R
2=0.32) of variance
adjusted for confounding factors such as sex and age, the most
significant predicting factors in the model were the BMI (beta=0.
298, p=0.02) and smoking habit (beta =0.229, p=0.03) and sex
(beta=0.440, p,0.001). Parameters of SDB such as the AHI,
nadir SaO2 and TST,90% or parameters of lipid profile were not
significant predicting variables. As regarding the level of antiox-
idant capacity (BAP), minimal oxygen desaturation (be-
ta=20.240, p=0.02), and smoking habit (beta=20.150,
p=0.04) were the most significant factors included in a model
that explained about 25% of the variance. The AHI and
TST,90% or the BMI were not included in the model.
Discussion
Our results indicate that systemic oxidative stress in patients
with OSAS is not associated with the severity of sleep apnea itself
Table 1. Comparison between OSAS patients and control
subjects.
Variable OSAS (n=42)
Controls
(n=24) p-value
Sex (M:F) 27:15 12:12
Smokers (n-%) 16 (38%) 18(75%) ,0.01
Hypertension (n-%) 12 (28%) 6 (25%) 0.45
Age (yrs) 49.7612.8 42.9613.1 0.04
BMI (Kg/m
2) 34.468.5 33.369.5 0.62
AHI(events/h) 36.9624.1 3.262.5 ,0.001
Nadir SaO2(%) 78.669.7 90.962.5 ,0.001
TST,90% (%) 16.7622.7 0.0860.4 ,0.001
d-ROMs (Carr.U) 404.3698.3 476.4698.9 0.005
BAP (mmol/L) 2057.26561.7 2410.36304.9 0.005
Cholesterol (mg/dl) 224.1637.1 209.2639.5 0.13
LDL(mg/dl) 150.5630.9 132.5637.5 0.04
HDL (mg/dl) 47.9610.4 52.3613.1 0.14
Triglycerides (mg/dl) 139.7673.0 116.1665.7 0.19
doi:10.1371/journal.pone.0039172.t001
Table 2. Correlations of d-ROMs metabolites.
Variable Spearman r p-value
Age 20.121 0.33
BMI 0.332 0.006
AHI 20.259 0.03
TST,90% 20.222 0.18
Nadir SaO2 0.209 0.09
Cholesterol 20.197 0.11
HDL 0.266 0.03
LDL 20.226 0.06
Triglycerides 20.124 0.31
doi:10.1371/journal.pone.0039172.t002
Table 3. Correlations of BAP.
Variable Spearman r P value
Age 20.012 0.92
BMI 20.050 0.68
AHI 20.191 0.12
TST,90% 20.167 0.17
Nadir SaO2 0.294 0.01
Cholesterol 20.268 0.03
HDL 0.162 0.19
LDL 20.287 0.01
Triglycerides 20.386 0.001
doi:10.1371/journal.pone.0039172.t003
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contribution of sleep disordered breathing in the imbalance of
oxidant-antioxidant status might be better explained with a re-
duction of the antioxidant capacity in the presence of significant
hypoxia.
Oxidative stress has been assessed by direct measurements of
ROS and enzymes which are involved in ROS production or
indirect measurements of oxidized products of lipids, proteins, or
DNA. Reactive oxygen species (ROS) and free radicals have a very
short life making their direct measurement difficult. In this study
we used a simple method of evaluating the systemic oxidative stress
that has been developed in order to measure the concentration of
hydroperoxide induced by free radicals [24]. It has been
considered to be directly proportional to the quantity of reactive
oxygen metabolites (ROMs) indicating the level of oxidative stress
throughout the body.
Several studies have suggested the presence of increased
oxidative stress in sleep disordered breathing using various
markers of oxidative stress but there are many studies with
contrary findings. Earlier investigations [7,8] demonstrated in-
creased production of ROS in leucocytes of OSAS patients when
compared to controls. Other markers such as increased lipid
peroxidation [9,10,14] and oxidized DNA [11] assessed by
oxidized LDL autoantibodies, thiobarbituric acid reactive deriva-
tives (TBAR) and urinary 8-hydroxy-29-deoxyguanosine excretion
have been found higher in subjects with OSAS. In contrast, other
studies [17–20] could not demonstrate increased oxidative stress in
OSAS patients when compared with controls. Thus whether there
is increased oxidative stress in OSAS remains controversial.
Oxidative stress has been related to many factors that could be
acting as confounding factors in the relationship with sleep
apnea.These include obesity, smoking, age, hypertension, hyper-
lipidemia and diabetes [21]. In our study we investigated all these
possible confounding factors except for diabetes. We found that
obesity and smoking habit had a greater influence on the
development of oxidative stress than sleep apnea. The mean
levels of d- ROMs, which represent an overall estimation of
oxidative stress although found to be abnormally high in sleep
apnea patients were not higher than those in controls with similar
BMI. In fact, level of oxidative stress was found lower in sleep
apnea subjects despite similar degree of obesity, a finding that
could be explained by the higher percentage of smokers and
females in the control group. In multiple regression analysis,
oxidative stress was mostly associated with obesity, smoking habit
and female sex. Thus, although we found increased oxidative stress
in OSAS, it was better explained by the influence of obesity,
smoking and sex.
Our findings might be in contrast with previous studies showing
increased oxidative stress in OSAS but the confounding role of
obesity has not been well elucidated. In a recent study, the authors
reported higher TBAR in patients when compared obese patients
with obese controls but they failed to find higher oxidative stress in
overweight patients in comparison to overweight controls
[14].Other studies showed increased lipid peroxidation [9] or
levels of oxidized DNA [11] in OSAS patients in comparison with
controls but the control groups had a significantly lower BMI.
Enhanced levels of d-ROMS [12] have been reported in OSAS in
comparison with controls of similar BMI but the mean values of d-
ROMS were not different between the two groups indicating that
high levels of d-ROMs in patients could be explained by the
presence of obesity. Significant differences between patients and
controls have been found only when obese patients are compared
with non-obese controls with attenuation of the difference [18]
when obese patients are compared with obese controls.
According to recent evidence, obesity is an inflammatory state
linked to increased oxidative stress [22]. Several studies in
community based samples showed that BMI was independently
associated with systemic oxidative stress markers although the
presence of SDB has not been into consideration in general
population studies [21]. The mechanisms that link obesity with
oxidative stress are similar to those have been investigated in
OSAS [4,5]. It has been proposed that oxidative stress in obesity is
a response to hypoxia because of increased distance of the
enlarged adipocytes from the vasculature [25]. The common
coexistence of obesity with OSAS [1] and the common pathways
to oxidative stress and inflammation might explain the confound-
ing role of obesity in the relationship of sleep apnea with increased
oxidative stress.
The antioxidant status is the other counterpart in the generation
of oxidative stress. Since obesity, smoking or metabolic dysregula-
tion which are the most important factors leading to oxidative
stress present commonly in patients with OSAS the role of sleep
apnea could be explained by the enhancement of the oxidative
stress that already exists. The reduction of antioxidant activity by
sleep apnea could result in an imbalance of oxidant-antioxidant
status in favour of oxidative stress.
Several studies [13–16] have shown that obese or non-obese
sleep apnea patients have decreased antioxidant capacity in
comparison with controls. In contrast, other authors [17,19] have
found no difference in antioxidant enzymes activity between
OSAS and controls. In this study, we examined the antioxidant
activity with a test (BAP) that evaluates the total antioxidant
capacity of the blood. This test has never been investigated in
OSAS patients but it has been considered as a method with
reproducible results and used as a marker of antioxidant activity in
cardiovascular surgery [26]. We found that OSAS patients had
decreased values of BAP in comparison with control subjects.
Smoking is a known condition that reduces antioxidant capacity
and produces oxidative stress [21,27]. Although our controls
included more smokers than OSAS patients they had higher
values of BAP. However, the independent role of sleep apnea was
indicated by the significant predicting value of minimal saturation.
However, the AHI was not an important predicting factor of
antioxidant status in contrast to previous studies. Thus our results
demonstrate that hypoxia may have an additional effect on
antioxidant activity independent of obesity or smoking in
agreement with previous studies showing that antioxidant capacity
is reduced in nonobese patients [15] or overweight and obese
patients [14]. Mechanisms of hypoxia induced reduction of
antioxidant capacity may be associated with dysregulation of
genes involved in the modulation of ROS or enzymes involved in
the production of the antioxidant barriers.
Thereareseveralpotentiallimitationstoourstudy.Thenatureof
this study is mostly descriptive and causal relationships cannot be
detected.ThenumberofOSAS(i.e.42)patientswasnotequaltothe
number of control subjects (i.e.24) because it was difficult to have
many subjects with obesity and no evidence of OSAS. Moreover,
ourcontrol groupincludedsubjects referred withsymptomsofsleep
apneaandnothealthyindividuals.Thusthereisnotacontrolgroup
of nonobese, nonsmokers individuals that would elicitate the
relationship of oxidative stress with indices of OSAS. For this
reason, we used a current definition of hypopnea that detects even
minor degrees of SDB including upper airway resistance in order to
avoid the inclusion of mild SDB in the control group. We did not
exclude smokers and women from our study population. This could
have considerable bias effect on our results since female sex and
smokingarestronglyassociatedwithenhancedoxidativestress[27].
However this did not weaken our results since although more
Oxidative Stress and Sleep Apnea
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significance of nocturnal hypoxemia was effectively detected. The
presence of more female subjects in the control group could explain
thehighervaluesofoxidativestressinthecontrolgroup.Thelackof
data on the menopause status is also a limitation of this study since
presence of menopause could have an effect on oxidative stress. In
our nocturnal polysomnograms, we did not routinely monitor end
tidal carbon dioxide, thereby we are unable to determine the
possibility of a confounding influence of obesity hypoventilation in
someobesepatientsthatcouldaccountforincreasedoxidativestress.
Finally, our methods for estimating oxidative stress and antioxidant
capacity reflect the overall status and excludes non-hydroperoxide
related ROS mediated markers and also cellular anti-oxidant
capacity (glutathione, mitochondrial).
In conclusion, our results showed that obesity, smoking and sex
are the most important determinants of oxidative stress in OSAS
subjects. Sleep apnea might enhance oxidative stress through
a reduction of antioxidant capacity of blood due to hypoxia related
to respiratory events. Certainly prospective studies separately in
men and women with more and preferably non-obese and non-
smoking subjects are needed to clarify the independent role of
OSAS in producing oxidative stress.
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